National Institute of Health Clinical Trials
Item
Date
20 May 2020
Title
National Institute of Health Clinical Trials
Description
Andre Kalil, MD, MPH, leads a team at Nebraska Medicine in enrolling some of the first COVID-19 patients in a National Institute of Health clinical trial that started in February to study Remdesivir as a therapeutic treatment for the virus.
Rights
Courtesy of LuAnn Larson, RN, BSN, Director of Clinical Research Operations, UNMC Clinical Research Center
Identifier
3.1c.5.08.1